County
Brunswick County EMS
Brunswick County EMS (NC) carries 52 drugs across 183 dose entries in its current published protocol, effective 2024-07-08.
The current listed document is more than 24 months old and may be outdated.
Drugs and doses52
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 1000 mg | IV | not captured | standing | page 32 |
| Fever | adult | 325–1000 mg | PO | not captured | standing | page 32 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 32 |
| Fever | peds | 15 mg/kg | IV | not captured | standing | page 32 |
| Mild to moderate pain | adult | 1000 mg | IV | not captured | standing | page 33 |
| Mild to moderate pain | adult | 325–1000 mg | PO | not captured | standing | page 33 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 33 |
| Mild to moderate pain | peds | 15 mg/kg | IV | not captured | standing | page 33 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g/kg | PO | not captured | standing | page 176 |
| Other | peds | 1 g/kg | PO | not captured | standing | page 176 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV/IO | not captured | standing | page 84 |
| SVT | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 84 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5–5 mg | NEB | not captured | standing | page 59 |
| Asthma / bronchospasm | peds | 1.25–2.5 mg | NEB | not captured | standing | page 59 |
| Respiratory distress | adult | 2.5–5 mg | NEB | not captured | standing | page 59 |
| Respiratory distress | peds | 1.25–2.5 mg | NEB | not captured | standing | page 59 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 86 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | page 86 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 90 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 90 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 90 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 90 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 80 |
| Mild to moderate pain | adult | 324–650 mg | PO | not captured | standing | page 33 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 76 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 76 |
| Organophosphate poisoning | adult | 2 mg | IV/IO/IM | not captured | standing | page 178 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 111 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 2 g | IV/IO | not captured | standing | page 111 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | page 111 |
Ceftriaxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Sepsis | adult | 50 mg/kg | IV/IO | not captured | standing | page 41 |
| Sepsis | peds | 50 mg/kg | IV/IO | not captured | standing | page 41 |
| Trauma / hemorrhage | adult | 50 mg/kg | IV/IO | not captured | standing | page 130 |
| Trauma / hemorrhage | peds | 50 mg/kg | IV/IO | not captured | standing | page 130 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 10 mg | IV/IO/IM | not captured | standing | page 115 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 125–250 mL | IV/IO | not captured | standing | page 109 |
| Hypoglycemia | peds | <1 y/o: D10 5 mL/kg; 1-2 years: D25 2 mL/kg; >2 years: D50 1 mL/kg | IV/IO | not captured | standing | page 109 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Seizure | adult | 10 mg | PR | not captured | standing | page 37 |
| Seizure | adult | 5 mg | IV/IO | not captured | standing | page 37 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 37 |
| Seizure | peds | 0.5 mg/kg | PR | not captured | standing | page 37 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 84 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | PO | not captured | standing | page 107 |
| Allergic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 107 |
| Allergic reaction | peds | 1 mg/kg | PO | not captured | standing | page 107 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 107 |
| Dystonic reaction | adult | 50 mg | IV/IO/IM/PO | not captured | standing | page 46 |
| Dystonic reaction | peds | 1 mg/kg | IV/IO/IM/PO | not captured | standing | page 46 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 2–20 mcg/kg | IV/IO | not captured | standing | page 76 |
| Bradycardia | peds | 2–20 mcg/kg | IV/IO | not captured | standing | page 76 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | page 107 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 107 |
| Bradycardia | adult | 1–10 mcg | IV/IO | not captured | standing | page 76 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 76 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 74 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 74 |
| Respiratory distress | peds | 1 mg | NEB | not captured | standing | page 59 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 57 |
Famotidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 20 mg | IV/PO | not captured | standing | page 107 |
| Allergic reaction | peds | 20 mg | IV/PO | not captured | standing | page 107 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 50–75 mcg | IV/IO | not captured | standing | page 80 |
| Mild to moderate pain | adult | 50–100 mcg | IV/IO/IM/IN | not captured | standing | page 33 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 33 |
| Post-intubation sedation | adult | 50–75 mcg | IV/IO | not captured | standing | page 67 |
| Post-intubation sedation | peds | 1 mcg/kg | IV/IO | not captured | standing | page 67 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 40 mg | IV | not captured | standing | page 82 |
| CHF / pulmonary edema | adult | 40 mg | IV | not captured | standing | page 82 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 176 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 176 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 176 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 176 |
| Hypoglycemia | adult | 1–2 mg | IM | not captured | standing | page 109 |
| Hypoglycemia | peds | 0.1 mg/kg | IM | not captured | standing | page 109 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2–5 mg | IM | not captured | standing | page 48 |
| Agitation | peds | 1–5 mg | IM | not captured | standing | page 48 |
Heparin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| STEMI | adult | 60 unit/kg | IV/IO | not captured | standing | page 80 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 70 mg/kg | IV/IO | not captured | standing | page 167 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 167 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 400–600 mg | PO | not captured | standing | page 32 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | page 32 |
| Mild to moderate pain | adult | 400–600 mg | PO | not captured | standing | page 33 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | page 33 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 59 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | page 59 |
| Respiratory distress | adult | 0.5 mg | NEB | not captured | standing | page 59 |
| Respiratory distress | peds | 0.5 mg | NEB | not captured | standing | page 59 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg/kg | IV/IO | not captured | standing | page 49 |
| Agitation | adult | 4 mg/kg | IM | not captured | standing | page 49 |
| Mild to moderate pain | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 33 |
| Procedural sedation | adult | 1.5–2 mg/kg | IV/IO | not captured | standing | page 67 |
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | page 57 |
| RSI induction | adult | 4 mg/kg | IM | not captured | standing | page 57 |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | page 57 |
| RSI induction | peds | 2 mg/kg | IM | not captured | standing | page 57 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV/IO | not captured | standing | page 33 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 33 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV/IO | not captured | standing | page 33 |
| Mild to moderate pain | peds | 0.5 mg/kg | IM | not captured | standing | page 33 |
Levetiracetam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Post-intubation sedation | adult | 1 g | IV/IO | not captured | standing | page 67 |
| Post-intubation sedation | peds | 15 mg/kg | IV/IO | not captured | standing | page 67 |
| Seizure | adult | 1 g | IV/IO | not captured | standing | page 37 |
| Seizure | peds | 15 mg/kg | IV/IO | not captured | standing | page 37 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 20–50 mg | IV/IO | not captured | standing | page 289 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV/IO | not captured | standing | page 289 |
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 90 |
| Wide-complex tachycardia | peds | 1 mg/kg | IV/IO | not captured | standing | page 90 |
Loperamide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 4 mg | PO | not captured | standing | page 198 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1 mg | IV/IO | not captured | standing | page 48 |
| Agitation | adult | 2 mg | IM | not captured | standing | page 48 |
| Seizure | adult | 1 mg | IV/IO | not captured | standing | page 37 |
| Seizure | adult | 2 mg | IM | not captured | standing | page 37 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 37 |
| Seizure | peds | 0.1 mg/kg | IM | not captured | standing | page 37 |
| Narrow-complex tachycardia | adult | 1 mg | IV/IO | not captured | standing | page 86 |
| Narrow-complex tachycardia | adult | 2 mg | IM | not captured | standing | page 86 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 86 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 2 g | IV/IO | not captured | standing | page 59 |
| Respiratory distress | peds | 40 mg/kg | IV/IO | not captured | standing | page 59 |
| Seizure | adult | 2–4 g | IV/IO | not captured | standing | page 122 |
| Seizure | adult | 5–10 g | IM | not captured | standing | page 122 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | page 88 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 125 mg | IV/IO/IM | not captured | standing | page 115 |
| Allergic reaction | adult | 125 mg | IV/IO/IM | not captured | standing | page 107 |
| Allergic reaction | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 107 |
| Anaphylaxis | adult | 125 mg | IV/IO/IM | not captured | standing | page 107 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 107 |
| Respiratory distress | adult | 125 mg | IV/IO/IM | not captured | standing | page 59 |
| Respiratory distress | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 59 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 5 mg | IV/IO | not captured | standing | page 84 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5 mg | IV/IO/IN | not captured | standing | page 48 |
| Agitation | adult | 5 mg | IM | not captured | standing | page 48 |
| Agitation | peds | 0.1–0.2 mg/kg | IV/IO/IN | not captured | standing | page 48 |
| Agitation | peds | 0.1–0.2 mg/kg | IM | not captured | standing | page 48 |
| Hyperactive delirium | adult | 10 mg | IM | not captured | standing | page 49 |
| Hyperactive delirium | peds | 0.1–0.2 mg/kg | IM | not captured | standing | page 49 |
| Post-intubation sedation | adult | 2–2.5 mg | IV/IO | not captured | standing | page 67 |
| Post-intubation sedation | peds | 0.1–0.2 mg/kg | IV/IO | not captured | standing | page 67 |
| Procedural sedation | adult | 2.5 mg | IV/IO/IN | not captured | standing | page 48 |
| Procedural sedation | adult | 5 mg | IM | not captured | standing | page 48 |
| Procedural sedation | peds | 0.1–0.2 mg/kg | IV/IO/IN | not captured | standing | page 48 |
| Procedural sedation | peds | 0.1–0.2 mg/kg | IM | not captured | standing | page 48 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 37 |
| Seizure | adult | 2–2.5 mg | IV/IO | not captured | standing | page 37 |
| Seizure | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 37 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 37 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2–4 mg | IV/IO | not captured | standing | page 80 |
| CHF / pulmonary edema | adult | 2–4 mg | IV/IO | not captured | standing | page 146 |
| CHF / pulmonary edema | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 146 |
| Mild to moderate pain | adult | 4 mg | IV/IO/IM | not captured | standing | page 33 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 33 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IM/IN | not captured | standing | page 78 |
| Opioid overdose | adult | 0.4–2 mg | IV/IO/ET | not captured | standing | page 78 |
| Opioid overdose | peds | 0.1 mg/kg | IM/IN | not captured | standing | page 78 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/ET | not captured | standing | page 78 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.3–0.4 mg | SL | not captured | standing | page 80 |
| CHF / pulmonary edema | adult | 0.3–0.4 mg | SL | not captured | standing | page 82 |
| CHF / pulmonary edema | adult | 0.3–0.4 mg | SL | not captured | standing | page 82 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IO/IM/PO/ODT | not captured | standing | page 21 |
| Nausea / vomiting | adult | 4 mg | IV/IO/IM/PO/ODT | not captured | standing | page 21 |
| Nausea / vomiting | peds | 0.2 mg/kg | IV/IO/IM/PO/ODT | not captured | standing | page 21 |
| Nausea / vomiting | peds | 0.2 mg/kg | IV/IO/IM/PO/ODT | not captured | standing | page 21 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 tube (15 grams) | PO | not captured | standing | page 109 |
| Hypoglycemia | peds | 1/2 to 1 tube (7.5 - 15 grams) | PO | not captured | standing | page 109 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 spray | IN | not captured | standing | page 31 |
| Other | peds | 2 spray | IN | not captured | standing | page 31 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | page 118 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 600 mg | IV/IO/IM | not captured | standing | page 178 |
| Nerve agent exposure | peds | 15–25 mg/kg | IV/IO/IM | not captured | standing | page 178 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5 mg | IM/PO | not captured | standing | page 21 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 57 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 50 mEq | IV/IO | not captured | standing | page 111 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 111 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | page 57 |
Terbutaline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 0.25 mg | SQ | not captured | standing | page 60 |
| Respiratory distress | peds | 0.01 mg/kg | SQ | not captured | standing | page 60 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 1–2 g | IV/IO | not captured | standing | page 122 |
| Other | adult | 1 g | TOP | not captured | standing | page 31 |
| Trauma / hemorrhage | adult | 1 g | TOP | not captured | standing | page 29 |
| Trauma / hemorrhage | adult | 1–2 g | IV/IO | not captured | standing | page 133 |
Whole Blood
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 unit | IV/IO | not captured | standing | page 116 |
| Trauma / hemorrhage | peds | 10 mL/kg | IV/IO | not captured | standing | page 116 |
| Traumatic arrest | adult | 1 unit | IV/IO | not captured | standing | page 116 |
| Traumatic arrest | peds | 10 mL/kg | IV/IO | not captured | standing | page 116 |